Showing results (131-140 of 355) with videos related to

Sort By:
Pageof 36
Metabolites|July 25, 2019
Statistical Workflow for Feature Selection in Human Metabolomics DataJoseph Antonelli, Brian L Claggett, Mir Henglin, et al.
JACC. Heart Failure|October 10, 2024
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF TrialsHenri Lu, Brian L Claggett, Milton Packer, et al.
European Journal of Heart Failure|December 18, 2024
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trialsAlberto Foà, Maria A Pabon, Eugene Braunwald, et al.
Lancet (London, England)|August 30, 2022
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trialsMuthiah Vaduganathan, Kieran F Docherty, Brian L Claggett, et al.
European Journal of Heart Failure|July 26, 2024
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MIFinnian R Mc Causland, Martina M McGrath, Brian L Claggett, et al.
Journal of Cardiac Failure|May 27, 2024
Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF TrialMarat Fudim, Derek D Cyr, Jonathan H Ward, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 8, 2021
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERELi Shen, Brian L Claggett, Pardeep S Jhund, et al.
JAMA Cardiology|January 7, 2026
Social Determinants of Health and Clinical Outcomes in Hypertrophic CardiomyopathyNeha Hafeez, Brian L Claggett, Anjali T Owens, et al.
European Journal of Heart Failure|September 8, 2025
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trialJohn W Ostrominski, Brian L Claggett, Akshay S Desai, et al.
Pageof 36